natural pharmaceuticals derived From Cannabis and other medicinal plants

Recently Received Notice of Authorization from Health Canada for the Conduct of its Clinical Trial with its PPTGR topical product

Sponsored
AGORACOM NEWS FLASH

BREAKING NEWS!!!

Tetra Bio-Pharma Reports Approval by Health Canada of its Phase 1 Trial of dried Cannabis

  • Health Canada approved phase I clinical study of smoked cannabis

We are very pleased to announce the authorization of the Phase I clinical trial by TPD. This is an important milestone in the clinical development of smoked Cannabis in North America and we are proud to be working with Algorithme pharma, a Clinical Research Organization with many years of experience and expertise in the conduct of Phase I clinical studies, said Dr. Chamberland, Chief Science Officer.

Tbp large

Hub On AGORACOM / Read Release

 

Message: IIROC Trade Resumption - TBP

VANCOUVER, Feb. 16, 2017 /CNW/ - Trading resumes in:

Company: Tetra Bio Pharma Inc.

CSE Symbol: TBP

Resumption (ET): 1:15 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

 

To view this news release in HTML formatting, please use the following URL: http://www.newswire.ca/en/releases/archive/February2017/16/c6802.html

IIROC Inquiries 1-877-442-4322 (Option 2) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.Copyright CNW Group 2017

 

Share
New Message
Please login to post a reply